Spots Global Cancer Trial Database for Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC
Official Title: Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC
Study ID: NCT03614065
Conditions
Study Description
Brief Summary: Observe the effect os radiotherapy plus or not plus endostar in the treatment of brain metastasis in NSCLC
Detailed Description: The investigators will observe the time controlled by the brain lesion after the test and the total survival time of the patients. Meanwhile, during each follow-up, the investigators will extract cerebrospinal fluid for genomic analysis of cerebrospinal fluid
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Union Hospital, Wuhan, Hubei, China
Contact Details
Name: dong xiaorong, Dr
Affiliation: china goverment
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
